Between 2008 and 2020 in Japan, PAH severity at presentation decreased and oral/inhaled combination therapies became preferred.
Answers are grounded in this paper and cite their sources.
Supports earlier PAH detection in Japan; leaves open global generalizability and outcome impact.
The severity of PAH decreased over time in Japan. Oral/inhaled combination therapies were generally preferred. Physicians generally prescribed therapies after considering the patients' hemodynamics and clinical severity. (Japan Pulmonary Hypertension Registry [JAPHR]; UMIN000026680).
No takes yet. Share an insight, caveat, or question.
Tamura et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: